drug

MECTA SPECTRUM 5000Q ECT

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by University of Sao Paulo
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia
NCT02049021Phase 4Unknown

KOLs & investigators

1
Hélio Elkis, MD PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of Sao Paulo
company
trial
Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia
PHASE4
trial
indication
Schizophrenia
indication
Schizophrenia, Treatment-Resistant
indication
Super Refractory Schizophrenia
indication
Refractory Schizophrenia
indication
KOL
Hélio Elkis, MD PhD
KOL score —
person